Even as Johnson & Johnson has announced its intention to stop selling vaginal mesh implants, at least one other company intends to continue marketing them despite reports that the devices are severely injuring thousands of patients.
A Bloomberg report quotes Blaine Davis, Endo Health Solutions senior vice-president for corporate affairs, as saying: “As a company, we’re very committed to these categories. We are actually investing behind these products.”
Davis said the company, ...
continue reading...